Evolution of perioperative management of catecholamine-producing tumors

[1]  J. Phay,et al.  Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma , 2020, Annals of Surgical Oncology.

[2]  M. Behrends,et al.  International multicentre review of perioperative management and outcome for catecholamine‐producing tumours , 2020, The British journal of surgery.

[3]  M. Diener,et al.  Meta‐analysis of α‐blockade versus no blockade before adrenalectomy for phaeochromocytoma , 2020, The British journal of surgery.

[4]  I. Ilias,et al.  Addressing delays in the diagnosis of pheochromocytoma/paraganglioma , 2019, Expert review of endocrinology & metabolism.

[5]  A. Charalampopoulos,et al.  Pheochromocytoma , 2019, Endocrine regulations.

[6]  S. Sidhu,et al.  Randomized trial of low versus high carbon dioxide insufflation pressures in posterior retroperitoneoscopic adrenalectomy , 2018, Surgery.

[7]  M. Paul,et al.  Seesawing end-tidal carbon dioxide: portent of critical carbon dioxide embolism in retroperitoneoscopy , 2018, BMJ Case Reports.

[8]  M. Raffaelli,et al.  Hemodynamic instability during surgery for pheochromocytoma: comparing the transperitoneal and retroperitoneal approach in a multicenter analysis of 341 patients , 2018, Surgery.

[9]  Paul Lee,et al.  Preoperative alpha‐blockade in phaeochromocytoma and paraganglioma: is it always necessary? , 2017, Clinical endocrinology.

[10]  R. Casey,et al.  Is there an optimal preoperative management strategy for phaeochromocytoma/paraganglioma? , 2017, Clinical endocrinology.

[11]  H. Neumann,et al.  Perioperative &agr;-receptor blockade in phaeochromocytoma surgery: an observational case series† , 2017, British journal of anaesthesia.

[12]  W. Drake,et al.  Alpha blockade—not to be underdone , 2017, Clinical endocrinology.

[13]  D. Schroeder,et al.  Preoperative Levels of Catecholamines and Metanephrines and Intraoperative Hemodynamics of Patients Undergoing Pheochromocytoma and Paraganglioma Resection. , 2017, Urology.

[14]  M. Keegan.  Preoperative α-blockade in catecholamine-secreting tumours: fight for it or take flight? , 2017, British journal of anaesthesia.

[15]  P. Nguyen-Thi,et al.  Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients , 2016, Surgical Endoscopy.

[16]  G. Melnichenko,et al.  Russian Association of Endocrinologists clinical practice guidelines for diagnosis and treatment of pheochromocytoma and paraganglioma , 2015 .

[17]  J. Pasieka,et al.  Hemodynamic Stability During Pheochromocytoma Resection: Lessons Learned Over the Last Two Decades , 2015, Annals of Surgical Oncology.

[18]  T. Fahey,et al.  Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. , 2014, Surgery.

[19]  W. Young,et al.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[20]  B. Lang,et al.  High Pre-Operative Urinary Norepinephrine is an Independent Determinant of Peri-Operative Hemodynamic Instability in Unilateral Pheochromocytoma/Paraganglioma Removal , 2014, World Journal of Surgery.

[21]  C. Lubitz,et al.  Diagnosis and management of pheochromocytoma. , 2014, Current problems in surgery.

[22]  M. Marzola,et al.  Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features , 2014, Endocrine.

[23]  R. Fanelli,et al.  SAGES guidelines for minimally invasive treatment of adrenal pathology , 2013, Surgical Endoscopy.

[24]  H. Timmers,et al.  Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines? , 2013, The Journal of clinical endocrinology and metabolism.

[25]  Jeffrey E. Lee,et al.  Posterior retroperitoneoscopic adrenalectomy. , 2009, Advances in surgery.

[26]  K. Pacak.  Preoperative management of the pheochromocytoma patient. , 2007, The Journal of clinical endocrinology and metabolism.

[27]  X. Capdevila,et al.  Transpulmonary thermodilution hemodynamic monitoring for pheochromocytoma surgery in a child with complex congenital heart disease , 2006, Paediatric anaesthesia.

[28]  Anastasios Deligiannis,et al.  Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients. , 2006, Surgery.

[29]  L. Sibal,et al.  Phaeochromocytomas presenting as acute crises after beta blockade therapy , 2006, Clinical endocrinology.

[30]  J. Farndon,et al.  Efficacy and Safety of Doxazosin for Perioperative Management of Patients with Pheochromocytoma , 2002, World Journal of Surgery.

[31]  M. Warner,et al.  Perioperative management of pheochromocytoma. , 2002, Journal of cardiothoracic and vascular anesthesia.

[32]  T. P. Fox,et al.  Pheochromocytoma in an incidentally discovered asymptomatic cystic adrenal mass. , 2000, Mayo Clinic proceedings.

[33]  J. Yoshikawa,et al.  A dopamine-secreting pheochromocytoma. , 1999, The American journal of medicine.

[34]  R. Giebler,et al.  Hemodynamic Changes After Retroperitoneal CO2 Insufflation for Posterior Retroperitoneoscopic Adrenalectomy , 1996, Anesthesia and analgesia.

[35]  E. Eger,et al.  A PROSPECTIVE RANDOMIZED TRIAL OF FOUR ANESTHETIC TECHNIQUES FOR RESECTION OF PHEOCHROMOCYTOMA , 1982 .

[36]  J. Farndon,et al.  Phaeochromocytomas in 72 patients: Clinical and diagnostic features, treatment and long term results , 1979, The British journal of surgery.